Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Ispire Technology Inc. manufactures e-cigarettes and cannabis vaping products. The company was founded in 2019 and is based in Los Angeles, California. Ispire Technology Inc. operates as a subsidiary of Pride Worldwide Investment Limited

Ispire Technology Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

PARTNERSHIP COMBINES PHARMACEUTICAL-GRADE MANUFACTURING WITHISPIRE'S GLOBAL PLATFORM TO ACCELERATE ENTRY INTO ONE OF THE FASTEST-GROWING NICOTINE SEGMENTS LOS ANGELES, MAY 12, 2026 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. ("ISPIRE" OR THE "COMPANY") (NASDAQ: ISPR), A TRAILBLAZER IN VAPING TECHNOLOGY AND PRECISION DOSING, ANNOUNCED THAT IT HAS ENTERED INTO A JOINT VENTURE WITH SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD. (SZSE: 300233) ("JINCHENG PHARMA"), A GLOBAL PHARMACEUTICAL COMPANY, TO MANUFACTURE AND COMMERCIALIZE NICOTINE POUCH PRODUCTS.

ISPIRE TECHNOLOGY EXPANDS INTO HIGH-GROWTH NICOTINE POUCH MARKET THROUGH STRATEGIC JOINT VENTURE WITH JINCHENG PHARMA

CASH INCREASED SEQUENTIALLY BY $468,000 TO $18 MILLION PLANS TO ACHIEVE CASH FLOW POSITIVE IN SECOND HALF OF CALENDAR YEAR 2026 BUSINESS STABILIZED FOLLOWING STRATEGIC REPOSITIONING PHASED ROADMAP TARGETS BILLIONS IN ADDRESSABLE MARKET, INCLUDING ~$73B GLOBAL VAPE, ~$5070B U.S. FLAVORED VAPE, AND $24B+ GLOBAL G-MESH GLASS TECHNOLOGY LOS ANGELES, MAY 7, 2026 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC.(NASDAQ: ISPR)("ISPIRE," THE "COMPANY," "WE," "US," OR "OUR"), AN INNOVATOR IN VAPING TECHNOLOGY AND PRECISION DOSING, TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER OF FISCAL 2026, FOR THE THREE MONTHS ENDED MARCH 31, 2026. MICHAEL WANG, CO-CHIEF EXECUTIVE OFFICER OF ISPIRE, COMMENTED, "THIS QUARTER REFLECTS THE SUCCESSFUL STABILIZATION OF OUR BUSINESS AND WITH CASH GROWING SEQUENTIALLY BY $468,000 TO $18 MILLION, WE ARE NOW EXECUTING AGAINST A PHASED ROADMAP, WITH NEAR-TERM REVENUE DRIVERS ALREADY IN PRODUCTION AND TRANSFORMATIVE TECHNOLOGY OPPORTUNITIES ON THE HORIZON: OUR MALAYSIA MANUFACTURING IS LIVE TODAY, GIVING US A 25% TARIFF ADVANTAGE OVER CHINA IN A ~$73B GLOBAL VAPE MARKET.

ISPIRE TECHNOLOGY INC. REPORTS FINANCIAL RESULTS FOR FISCAL THIRD QUARTER 2026

LOS ANGELES, MAY 1, 2026 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. ("ISPIRE" OR THE "COMPANY") (NASDAQ: ISPR), A TRAILBLAZER IN VAPING TECHNOLOGY AND PRECISION DOSING, ANNOUNCED TODAY THAT IT WILL HOST ITS EARNINGS CONFERENCE CALL AT 8:00 AM ET ON THURSDAY, MAY 7, 2026, TO DISCUSS THE COMPANY'S FINANCIAL RESULTS FOR ITS FISCAL THIRD QUARTER ENDED MARCH 31, 2026. TO LISTEN TO THE CONFERENCE CALL, PLEASE DIAL IN USING THE INFORMATION BELOW.

ISPIRE TECHNOLOGY INC. SCHEDULES FISCAL THIRD QUARTER 2026 EARNINGS CONFERENCE CALL

DUAL HONORS AT GAAS SUMMIT UNDERSCORE GROWING REGULATORY AND COMMERCIAL VALIDATIONFOR IKETECH'S POINT-OF-USE, PRIVACY-FIRST COMPLIANCE PLATFORM LOS ANGELES, APRIL 23, 2026 /PRNEWSWIRE/ -- IKETECH LLC , AN AI-POWERED COMPLIANCE INFRASTRUCTURE COMPANY AND JOINT VENTURE AMONG ISPIRE TECHNOLOGY INC. (NASDAQ: ISPR ), BERIFY , AND CHEMULAR INC. , ANNOUNCED IT HAS RECEIVED DUAL RECOGNITION AT THE AGE ASSURANCE INDUSTRY AWARDS 2026, PRESENTED AT THE GLOBAL AGE ASSURANCE STANDARDS SUMMIT (GAAS) IN MANCHESTER, UK. THE COMPANY WAS NAMED WINNER OF "PRIVACY-CENTRIC AGE ASSURANCE SOLUTION OF THE YEAR" AND ALSO RECEIVED HIGHLY COMMENDED FOR "INNOVATION IN AGE ASSURANCE TECHNOLOGY," STANDING OUT AMONG A COMPETITIVE INTERNATIONAL FIELD OF ENTRANTS.

IKETECH WINS "PRIVACY-CENTRIC AGE ASSURANCE SOLUTION OF THE YEAR," RECOGNIZED FOR INNOVATION AT GLOBAL INDUSTRY AWARDS

COMPANIES OUTLINE PUBLIC HEALTH CASE FOR POINT-OF-USE ENFORCEMENT TECHNOLOGIES AND CALL FOR REGULATORY FRAMEWORK RECOGNIZING COMPLIANCE SOFTWARE AS A TOBACCO PRODUCT LOS ANGELES, APRIL 9, 2026 /PRNEWSWIRE/ -- IKE TECH LLC ("IKE TECH"), AN AI-POWERED COMPLIANCE INFRASTRUCTURE COMPANY AND JOINT VENTURE AMONG ISPIRE TECHNOLOGY INC. (NASDAQ: ISPR), BERIFY, AND CHEMULAR INC., PARTICIPATED IN A FORMAL LISTENING SESSION WITH THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA) CENTER FOR TOBACCO PRODUCTS (CTP). DURING THE SESSION, IKE TECH PRESENTED THE PUBLIC HEALTH CASE FOR POINT-OF-USE COMPLIANCE TECHNOLOGY TO PREVENT YOUTH USAGE OF ENDS PRODUCTS, ITS PATENTED HUMAN IDENTITY TOKEN (HIT) TECHNOLOGY, AND OUTLINED THE NEED FOR A REGULATORY FRAMEWORK ADDRESSING SOFTWARE AS A TOBACCO PRODUCT.

IKE TECH ENGAGES FDA ON NEXT-GENERATION COMPLIANCE INFRASTRUCTURE FOR ENDS

FDA ESTABLISHES FIRST-EVER FRAMEWORK FOR FLAVORED ENDS, RECOGNIZING DEVICE LEVEL AGE VERIFICATION AS A REGULATORY REQUIREMENT FDA GUIDANCE UNLOCKS AN ESTIMATED $50 BILLION TOTAL ADDRESSABLE MARKET, ALLOWING COMPANIES TO LAWFULLY TRANSITION THE 70% ILLICIT FLAVOREDVAPE MARKET INTO A COMPLIANT ECOSYSTEM ISPIRE'S 40%-OWNED IKE TECH JOINT VENTURE IS POSITIONED TO GENERATE $5 MILLION TO $20 MILLION IN ANNUAL RECURRING SAAS REVENUE PER CUSTOMER IN THE US BASED ON CONSERVATIVE SAAS METRICS, EVEN A LIMITED NUMBER OF CUSTOMERS COULD POTENTIALLY VALUE THEIKE JOINT VENTURE IN THE HUNDREDS OF MILLIONS, DRAMATICALLY INCREASING ISPIRE'S BOOK VALUE ISPIRE-BACKED IKE TECH WAS FIRST TO FILE COMPONENT PMTA FOR CONTINUOUS, BLOCKCHAIN-ENABLED AGE-GATING TECHNOLOGY LOS ANGELES, MARCH 16, 2026 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. ("ISPIRE" OR THE "COMPANY") (NASDAQ: ISPR), A TRAILBLAZER IN VAPING TECHNOLOGY AND PRECISION DOSING, TODAY HIGHLIGHTED THE MASSIVE ECONOMIC VALUE AND MULTI-BILLION-DOLLAR MARKET OPPORTUNITY CREATED FOR ITS SHAREHOLDERS BY THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA) NEWLY ISSUED DRAFT GUIDANCE OUTLINING EVIDENTIARY EXPECTATIONS FOR PREMARKET TOBACCO PRODUCT APPLICATIONS (PMTAS) FOR FLAVORED ELECTRONIC NICOTINE DELIVERY SYSTEMS (ENDS). THE FDA'S GUIDANCE EFFECTIVELY UNLOCKS A $50 BILLION TOTAL ADDRESSABLE MARKET BY PROVIDING A LAWFUL PATHWAY FOR FLAVORED VAPES, WHICH CURRENTLY CONSIST LARGELY OF ILLICIT PRODUCTS.

ISPIRE HIGHLIGHTS ECONOMIC IMPACT OF NEW FDA GUIDANCE ON FLAVORED ENDS UNLOCKING A $50 BILLION MARKET AND DRIVING SIGNIFICANT POTENTIAL ASSET VALUE

LOS ANGELES, MARCH 11, 2026 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. ( NASDAQ: ISPR ) ("ISPIRE," THE "COMPANY," "WE," "US," OR "OUR"), AN INNOVATOR IN VAPING TECHNOLOGY AND PRECISION DOSING, TODAY ANNOUNCED THAT ISPIRE'S MANAGEMENT TEAM WILL PARTICIPATE IN THE 38TH ANNUAL ROTH CONFERENCE TAKING PLACE IN DANA POINT, CALIFORNIA FROM MARCH 22-24, 2026. 38TH ANNUAL ROTH CONFERENCE DATE: MARCH 22-24, 2026 LOCATION: DANA POINT, CALIFORNIA FIRESIDE CHAT DETAILS: MONDAY, MARCH 23, 2026, AT 8:00 A.M.

ISPIRE TECHNOLOGY INC. TO PARTICIPATE IN THE 38TH ANNUAL ROTH CONFERENCE

ONGOING FOCUS ON COLLECTIONS DRIVES 19% REDUCTION IN NET ACCOUNTS RECEIVABLE SINCE JUNE 30, 2025 CASH  OF $17.6 MILLION AT DECEMBER 31, 2025  LOS ANGELES, FEB. 6, 2026 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. (NASDAQ: ISPR)("ISPIRE," THE "COMPANY," "WE," "US," OR "OUR"), AN INNOVATOR IN VAPING TECHNOLOGY AND PRECISION DOSING, TODAY REPORTED FINANCIAL RESULTS FOR THE SECOND QUARTER OF FISCAL 2026, FOR THE THREE MONTHS ENDED DECEMBER 31, 2025. FISCAL SECOND QUARTER 2026 FINANCIAL RESULTS REVENUE OF $20.3 MILLION VERSUS $41.8 MILLION FOR THE SECOND QUARTER OF FISCAL 2025.

ISPIRE TECHNOLOGY INC. REPORTS FINANCIAL RESULTS FOR FISCAL SECOND QUARTER 2026

INVITATION-ONLY FORUM UNDERSCORES FDA RECOGNITION OF IKE TECH AS A KEY STAKEHOLDER AND HIGHLIGHTS THE STRATEGIC ROLE OF AGE-GATING TECHNOLOGY IN THE FUTURE OF ENDS REGULATION AND COMPLIANCE LOS ANGELES, FEB. 4, 2026 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. ("ISPIRE" OR THE "COMPANY") (NASDAQ: ISPR), A TRAILBLAZER IN VAPING TECHNOLOGY AND PRECISION DOSING, ANNOUNCED THAT IKE TECH LLC ("IKE TECH" OR "IKE"), A JOINT VENTURE THAT INCLUDES ISPIRE AS A FOUNDING PARTNER, HAS BEEN INVITED BY THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) TO PARTICIPATE IN ITS ROUNDTABLE DISCUSSION WITH SMALL ENDS MANUFACTURERS ON PREMARKET TOBACCO PRODUCT APPLICATION (PMTA) SUBMISSIONS. THE INVITATION-ONLY ROUNDTABLE, TAKING PLACE FEBRUARY 10, IS THE FIRST FDA FORUM OF ITS KIND FOCUSED ON GATHERING DIRECT FEEDBACK FROM SELECT ELECTRONIC NICOTINE DELIVERY SYSTEM (ENDS) MANUFACTURERS ON THE PMTA PROCESS.

ISPIRE-BACKED IKE TECH INVITED TO PARTICIPATE IN FDA ROUNDTABLE ON PMTA SUBMISSIONS

LOS ANGELES, FEB. 3, 2026 /PRNEWSWIRE/ -- ISPIRE TECHNOLOGY INC. ("ISPIRE" OR THE "COMPANY") (NASDAQ: ISPR), A TRAILBLAZER IN VAPING TECHNOLOGY AND PRECISION DOSING, ANNOUNCED TODAY THAT IT WILL HOST ITS EARNINGS CONFERENCE CALL AT8:00 AM ETONFRIDAY, FEBRUARY 6, 2026, TO DISCUSS THE COMPANY'S FINANCIAL RESULTS FOR ITS FISCAL SECOND QUARTER ENDEDDECEMBER 31, 2025. TO LISTEN TO THE CONFERENCE CALL, PLEASE DIAL IN USING THE INFORMATION BELOW.

Ispire Technology Inc.

ISPR

Price

Financial Reports

No items found.

Press Releases

Ispire Technology Inc.

ISPR.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

ISPR